Natalie L Kingston

9PUBLICATIONS
110CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer cell biologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.

Graham D Hogg, Alyssa G Weinstein, Natalie L Kingston

|Jun 02, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.

Zheqi Li, Guillermo Peluffo, Laura E Stevens

|Jun 07, 2023
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer.

Brett H Herzog, John M Baer, Nicholas Borcherding

|May 25, 2023
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.

C Alston James, John M Baer, Chong Zou

|May 02, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.

Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova

|Mar 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy.

Chong Zuo, John M Baer, Brett L Knolhoff

Pageof 2

Frequent Collaborators

6 joint publications

Graham Hogg

5 joint publications

David G DeNardo

5 joint publications

Brett L Knolhoff

4 joint publications

Liang-I Kang